The CEO of Lyndra Therapeutics describes the company's technology that turns daily pills into weekly ones - and potentially longer
Jessica Ballinger describes the science behind this and how an extended release format can improve health outcomes. Plus, the progress Lyndra has made developing a risperidone based product, and other areas this might be used for.